The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, ...

While these outbreaks of categories can certainly expose Prestige to new competition, we believe it also affords the firm a new set of customers that it can win over. And given Prestige’s focus in ...

Consumer health company Kenvue Inc. (NYSE:KVUE) on Thursday reported first-quarter 2025 sales of $3.74 billion, beating the ...

Kenvue (NYSE:KVUE) recently appointed Amit Banati as its new CFO, an executive change aligning with its strategy to augment shareholder value. Concurrently, the company raised its net sales guidance ...

The National Institute of Mental Health and the National Institute on Minority Health and Health Disparities lost the most ...

Amit Banati, 56, will succeed CFO Paul Ruh at Summit, New Jersey-based Kenvue, formerly the consumer healthcare division of ...

Discover Kenvue's Q1 2025 earnings insights—strategic growth, tariff mitigation, innovation focus, and supply chain resilience to drive performance this year.

Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...

JP Morgan has bolstered its green finance and advisory offering in Europe with a new division head to support clients across ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the ...